Effects of tumor necrosis factor-α, interleukin-23 and interleukin-17A inhibitors on bodyweight and body mass index in patients with psoriasis. [electronic resource]
Producer: 20181211Description: 1130-1134 p. digitalISSN:- 1346-8138
- Adult
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Humanized
- Biological Products -- pharmacology
- Body Mass Index
- Body Weight -- drug effects
- Dermatologic Agents -- pharmacology
- Female
- Humans
- Infliximab -- pharmacology
- Interleukin-17 -- antagonists & inhibitors
- Interleukin-23 Subunit p19 -- antagonists & inhibitors
- Male
- Middle Aged
- Psoriasis -- drug therapy
- Retrospective Studies
- Severity of Illness Index
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
- Ustekinumab -- pharmacology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.